Articles From: Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Liquidity Services, Inc. -- LQDT to Galectin Therapeutics to Host Webcast to Discuss Findings From Cohort 2 of Phase 1 Clinical Trial of GR-MD-02 in Fatty Liver Disease With Advanced Fibrosis


NEW YORK, July 17, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the District of Columbia on behalf of all persons who purchased or otherwise acquired the securities of Liquidity Services, Inc. ("Liquidity Services" or the "Company") (Nasdaq:LQDT) during the period between February 1, 2012 through May 7, 2014, inclusive (the "Class Period") (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"). The Complaint alleges that throughout the Class Period, Liquidity Services falsely represented the financial condition of the Company in issuing false and misleading statements concerning the Company's current and future profitability, its growth initiatives including the integration and performance of its acquisitions, the seriousness
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Liquidity Services, Inc. -- LQDT investment picks
NEW YORK, July 18, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the Eastern District of Virginia on behalf of all persons who purchased or otherwise acquired the securities of NeuStar, Inc. ("NeuStar" or the "Company") (NYSE:NSR) during the period between April 19, 2013 and June 6, 2014, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"). The Complaint alleges that the Company misled investors regarding its ability to maintain a series of contracts with North American Portability Management LLC.
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against NeuStar, Inc. -- NSR investment picks
NEW YORK, July 16, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court, District of New Jersey on behalf of all persons who purchased or otherwise acquired the securities of Regado Biosciences, Inc. ("Regado" or the "Company") (Nasdaq:RGDO) during the period between August 22, 2013 and July 9, 2014, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"). The Complaint alleges that throughout the Class Period, Defendants made false and/or materially misleading statements about the Company's business, operations, prospects and performance.
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Regado Biosciences, Inc. -- RGDO investment picks
NEW YORK, July 10, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of all persons who purchased or otherwise acquired the securities of STAAR Surgical Company ("STAAR" or the "Company") (Nasdaq:STAA) during the period between February 27, 2013 and June 30, 2014.
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against STAAR Surgical Company investment picks
NEW YORK, July 18, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed in the United States District Court, District of Delaware on behalf of all persons who purchased or otherwise acquired the securities of The Bancorp, Inc. ("The Bancorp" or the "Company") (Nasdaq:TBBK) during the period between April 24, 2013 and June 10, 2014, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"). The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding (i) the Company had under-reserved for loan losses due to adverse loans; and (ii) the Company's operations and credit practices were in violation of the Bank Secrecy Act ("BSA"). As a result of the above, the Complaint alleges the Company's financial
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against The Bancorp, Inc. -- TBBK investment picks
NEW YORK, July 25, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that they have filed a class action lawsuit on behalf of their client and others in the United States District Court for the Central District of California on behalf of all persons who purchased or otherwise acquired the securities of NetSol Technologies, Inc. ("NetSol" or the "Company") (Nasdaq:NTWK) during the period between March 10, 2011 and November 8, 2013, inclusive (the "Class Period") (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act"). The Complaint alleges that throughout the Class Period, Defendants issued materially false and/or misleading statements because: (a) NetSol's next generation product was not expected to be completed when promised by the Company; (b) serious interest in NetSol's next generation solution had not been
Sign-up for Gainey McKenna & Egleston Announces They Have Filed a Class Action Lawsuit Against NetSol Technologies, Inc. -- NTWK investment picks
2014/7/28
NEW YORK, July 28, 2014 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston has filed the first and only class action lawsuit and issues a corrected notice to clarify the class period.
Sign-up for Gainey McKenna & Egleston Filed the First and Only Securities Class Action Lawsuit Against NetSol Technologies, Inc. and Issues a Corrected Notice to Clarify Class Period -- NTWK investment picks
LAS VEGAS, Aug.
Sign-up for Galaxy Gaming Enters Czech Republic investment picks
LAS VEGAS, June 25, 2014 (GLOBE NEWSWIRE) -- Galaxy Gaming, Inc. (OTC:GLXZ) the world's largest independent producer of casino table games and enhanced systems, announced today the installation of its proprietary table games in France.
Sign-up for Galaxy Gaming Expands Its European Operations Into France investment picks
2014/9/26
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147556&ProfileId=051205&sourceType=1 NEW ORLEANS, LA --
Sign-up for GALECTIN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against Galectin Therapeutics Inc. - GALT investment picks
NEW ORLEANS, July 31, 2014 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C.
Sign-up for GALECTIN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Galectin Therapeutics Inc. -- GALT investment picks
2014/8/11
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a federal class action lawsuit has been filed against Galectin Therapeutics, Inc. (“Galectin” or “Company”) (NasdaqCM: GALT) and several officers and directors for acts taken during the period of January 6, 2014 to July 28, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Galectin.
Sign-up for Galectin Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Galectin Therapeutics Inc. (NASDAQ: GALT) violated state or federal laws.
Sign-up for GALECTIN SHAREHOLDERS NOTICE: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Galectin Therapeutics Inc. investment picks
NORCROSS, Ga., July 9, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT) , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced that it has been added to the Russell 3000® Index and Russell 2000® Index when Russell Investments reconstituted its comprehensive set of U.S. and global equity indexes on June 27, 2014.
Sign-up for Galectin Therapeutics Added to Russell 2000 Index investment picks
NORCROSS, Ga., July 22, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (Nasdaq:GALT) , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the first patient has been dosed in cohort 1 of the Company's Phase 1B clinical trial evaluating GR-MD-02 in combination with ipilimumab (Yervoy®) in patients with metastatic melanoma.
Sign-up for Galectin Therapeutics Announces First Patient Dosed in Cohort 1 of Phase 1B Clinical Trial of GR-MD-02 in Combination with Ipilimumab in Metastatic Melanoma investment picks
NORCROSS, Ga., July 30, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics (Nasdaq:GALT) , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced yesterday results of cohort 2 of its phase 1 clinical trial in patients with NASH with advanced fibrosis.
Sign-up for Galectin Therapeutics Issues Statement on GR-MD-02 Development Program investment picks
NORCROSS, Ga., Aug.
Sign-up for Galectin Therapeutics Receives U.S. Patent for GR-MD-02 Composition of Matter investment picks
NORCROSS, Ga., Aug.
Sign-up for Galectin Therapeutics Reports Second Quarter 2014 Financial Results investment picks
NORCROSS, Ga., Aug.
Sign-up for Galectin Therapeutics Responds to Class Action Lawsuit investment picks
NORCROSS, Ga., July 25, 2014 (GLOBE NEWSWIRE) -- Galectin Therapeutics (Nasdaq:GALT) , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced the Company will hold a webcast on Tuesday, July 29, 2014 at 8:30 a.m. Eastern Daylight Time to discuss the findings from cohort 2 of a Phase 1 clinical trial evaluating its galectin inhibitor GR-MD-02 in fatty liver disease (NASH) with advanced fibrosis.
Sign-up for Galectin Therapeutics to Host Webcast to Discuss Findings From Cohort 2 of Phase 1 Clinical Trial of GR-MD-02 in Fatty Liver Disease With Advanced Fibrosis investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Liquidity Services, Inc. -- LQDT to Galectin Therapeutics to Host Webcast to Discuss Findings From Cohort 2 of Phase 1 Clinical Trial of GR-MD-02 in Fatty Liver Disease With Advanced Fibrosis
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices